Black Stallion Oil & Gas, Inc. (OTC Pink: BLKG) is engaged as an oil & as company. Shares of the energy company are gaining 20%, through early trading on Wednesday, August 9, 2017. Over the past month, Black Stallion Oil & Gas, Inc. has seen average daily volume of 33.61 million shares. However, volume of 128.98 million shares or dollar volume of $77,388, has already exchanged hands on Wednesday.
Shares of Black Stallion Oil & Gas, Inc. are rallying today, after the company announced it has signed a Letter of Intent to enter into a licensing and distribution agreement with Active Lab International. Under the terms of the deal, Black Stallion Oil & Gas, Inc. will provide marketing and sales assistance to Active Lab. Here is the full press release detailing of the exclusive licensing and distribution agreement:
Black Stallion Oil & Gas, Inc. Press Release:
LOS ANGELES, CA — (Marketwired) — 08/09/17 — Black Stallion Oil & Gas, Inc. (OTC PINK: BLKG) (the “Company,” “Black Stallion”), a company that has determined to add additional revenue streams through strategic relationships with innovative companies, has signed a Letter of Intent (“LOI”) with Active Lab International, Inc. (“Active Lab”), to enter into a licensing and distribution agreement for various products of Active Lab.
The licensing and distribution agreement requires Black Stallion to provide the marketing and sales platforms, as well as various administrative functions, for Active Lab.
Active Lab will use Black Stallion’s services to further launch its existing products, incorporating its proprietary CitrusDefence™, as well as Active Lab’s recent addition to its product line, Synapset™. CitrusDefence™ products are for household and personal care. Synapset™ is currently being sold in Canada, where it was developed as a cognizant enhancer for people. Canada’s Health Services, equivalent to the United States Food and Drug Administration (“FDA”), as a result of clinical results, has authorized the product for distribution with claims that Synapset™ has shown positive attributes in regards to Attention Deficit Disorder (“ADD”) and Attention Deficit Hyperactivity Disorder (“ADHD”). Active Lab will be seeking the similar authorizations from the FDA. Additional clinical studies are being performed for other claims.
This agreement with Active Lab serves as a “launching pad” for the next phase of the corporate strategy that Black Stallion is seeking to implement. Active Lab, a nutraceutical company with an online presence, provides a unique opportunity to add shareholder value as the Company establishes a long-term plan to address various global market conditions.
“We are pleased that we could come to terms with Active Lab and set the stage for further growth, diversification, and expansion. We are particularly excited to work with an established company that already has an established Internet footprint, with companies like Amazon,” stated Ira Morris, CEO of Black Stallion. “Our future will follow this strategic planning whereas the partner, like Active Lab, will receive a royalty for the licensing and distribution.”
About Black Stallion Oil & Gas, Inc.
Black Stallion Oil & Gas, Inc. (BLKG) is an energy based business that is expanding its offerings to align itself with companies in various industries.
Forward looking statement:
This press release contains certain “forward-looking statements,” as defined in the United States PSLRA of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management’s current expectations. The economic, competitive, governmental, technological and other factors identified in the Company’s previous filings with the Securities and Exchange Commission may cause actual results or events to differ materially from those described in the forward-looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Notice Regarding Forward-Looking Statements
This news release contains “forward-looking statements.” Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the filing of two additional patents, the growth of the Company’s retail division and the expansion of the company’s operations and product offerings. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.